Current status and future perspectives of liquid biopsy in non-small cell lung cancer

Current status and future perspectives of liquid biopsy in non-small cell lung cancer

With advances in target therapy, molecular analysis of tumors is routinely required for treatment decisions in patients with advanced non-small cell lung cancer (NSCLC). Liquid biopsy refers to the sampling and analysis of circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blo...

Full description

Bibliographic Details
Main Authors:	Sunhee Chang, Jae Young Hur, Yoon-La Choi, Chang Hun Lee, Wan Seop Kim
Format:	Article
Language:	English
Published:	Korean Society of Pathologists & the Korean Society for Cytopathology 2020-05-01
Series:	Journal of Pathology and Translational Medicine
Subjects:	carcinoma, non-small cell lung cancer liquid biopsy circulating tumor dna epidermal growth factor receptor biomarkers
Online Access:	http://www.jpatholtm.org/upload/pdf/jptm-2020-02-27.pdf

Similar Items

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
by: Minji Lim, et al.
Published: (2018-02-01)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
by: Zhuo eZhang, et al.
Published: (2015-09-01)

The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
by: Daniel Di Capua, et al.
Published: (2021-08-01)

Future directions and management of liquid biopsy in non-small cell lung cancer
by: Alessia Maria Cossu, et al.
Published: (2020-08-01)

Provisional Guideline Recommendation for Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group
by: Dong Hoon Shin, et al.
Published: (2019-05-01)

Clinical Applications of Liquid Biopsy in Non-Small Cell Lung Cancer Patients: Current Status and Recent Advances in Clinical Practice
by: Shinhee Park, et al.
Published: (2021-05-01)

Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation
by: Ângela Carvalho, et al.
Published: (2021-04-01)

Advances in Liquid Biopsy and its Clinical Application in the Diagnosis  and Treatment of Non-small Cell Lung Cancer
by: Difan ZHENG, et al.
Published: (2016-06-01)

Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
by: Lanxiang Huang, et al.
Published: (2021-05-01)

Liquid Biopsy in Small Cell Lung Cancer—A Route to Improved Clinical Care?
by: Matt Church, et al.
Published: (2020-12-01)

The Liquid Biopsy in the Management of Colorectal Cancer: An Overview
by: Marco Vacante, et al.
Published: (2020-08-01)

Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers
by: Giovanni Vicidomini, et al.
Published: (2020-10-01)

Clinical Applications of Circulating Tumor DNA, Circulating Tumor Cells, and Exosomes as Liquid Biopsy-Based Tumor Biomarkers
by: Xiaoshuang Yan, et al.
Published: (2020-08-01)

ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients
by: Paul Hofman
Published: (2017-08-01)

Understanding the Mechanisms of Resistance in <em>EGFR</em>-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy
by: Marzia Del Re, et al.
Published: (2019-08-01)

What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy
by: Paul Hofman
Published: (2021-06-01)

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
by: Tang Y, et al.
Published: (2017-09-01)

The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
by: Arutha Kulasinghe, et al.
Published: (2018-08-01)

Liquid Biopsy, Diagnostic Imaging, and Future Synergies
by: Digumarthy, S.R, et al.
Published: (2022)

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure
by: Juan Zhou, et al.
Published: (2019-04-01)

Progress and application of circulating tumor cells in non-small cell lung cancer
by: Huizhu Qian, et al.
Published: (2021-09-01)

Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications
by: Dimple Chudasama, et al.
Published: (2019-03-01)

Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma
by: In Ae Kim, et al.
Published: (2020-11-01)

Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer
by: Aitor Rodriguez-Casanova, et al.
Published: (2021-02-01)

Non-invasive Detection of Exosomal MicroRNAs via Tethered Cationic Lipoplex Nanoparticles (tCLN) Biochip for Lung Cancer Early Detection
by: Chang Liu, et al.
Published: (2020-03-01)

Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies
by: Sandra P. Nunes, et al.
Published: (2019-09-01)

Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
by: Patricia Mondelo-Macía, et al.
Published: (2021-01-01)

Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies
by: Daniel G. Weber, et al.
Published: (2020-05-01)

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy
by: Simona Coco, et al.
Published: (2017-05-01)

Liquid Biopsy in Gastrointestinal Cancers
by: Aman Saini, et al.
Published: (2018-10-01)

Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer
by: Boris Duchemann, et al.
Published: (2020-12-01)

Liquid Biopsies in the Clinical Management of Germ Cell Tumor Patients: State-of-the-Art and Future Directions
by: João Lobo, et al.
Published: (2021-03-01)

Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
by: José Marrugo-Ramírez, et al.
Published: (2018-09-01)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01)

Liquid biopsy: the current state of the issue
by: E. A. Pasechnikova, et al.
Published: (2021-09-01)

The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
by: Cláudia Freitas, et al.
Published: (2021-04-01)

The Validity and Predictive Value of Blood-Based Biomarkers in Prediction of Response in the Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review
by: Frederik van Delft, et al.
Published: (2020-04-01)

Update on liquid biopsy in clinical management of non-small cell lung cancer
by: Wu Z, et al.
Published: (2019-07-01)

Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer
by: Elisa Gobbini, et al.
Published: (2020-10-01)

Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle
by: Elien Augustus, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_2r5hqle337d38ne3rjgapqm96u